Main

processing priority

4

site type

0 (generic, awaiting analysis)

review version

11

html import

40 (error)

Events

first seen date

2024-03-16 07:32:15

expired found date

-

created at

2024-06-01 21:41:29

updated at

2025-12-26 17:54:24

Domain name statistics

length

10

crc

34029

tld

2211

nm parts

0

nm random digits

0

nm rare letters

0

Connections

is subdomain of id

-

previous id

0

replaced with id

0

related id

-

dns primary id

256482523

dns alternative id

0

lifecycle status

0 (unclassified, or currently active)

Subdomains and pages

deleted subdomains

0

page imported products

0

page imported random

0

page imported parking

0

Error counters

count skipped due to recent timeouts on the same server IP

0

count content received but rejected due to 11-799

0

count dns errors

0

count cert errors

0

count timeouts

0

count http 429

0

count http 404

0

count http 403

0

count http 5xx

0

next operation date

-

Server

server bits

server ip

-

Mainpage statistics

mp import status

20

mp rejected date

-

mp saved date

-

mp size orig

416832

mp size raw text

4660

mp inner links count

2

mp inner links status

20 (imported)

Open Graph

title

Homepage - MABLOC | IMMUNITY FOR HUMANITY

description

Immunityfor Humanity A new era for combatting infectious diseases. We are a biotechnology company developing monoclonal antibodies to revolutionize the treatment of infectious diseases. We target dise

site name

MABLOC | IMMUNITY FOR HUMANITY - Somos o único laboratório independente do mundo que busca anticorpos monoclonais multivalentes que podem revolucionar o tratamento de doenças infecciosas como COVID-19

author

updated

2025-12-14 06:09:37

raw text

Homepage - MABLOC | IMMUNITY FOR HUMANITY Skip to content IMMUNITY FOR HUMANITY News Experts About Our Partners Antibodies Publications Contact Navigation Menu Navigation Menu News Experts About Our Partners Antibodies Publications Contact Immunity for Humanity A new era for combatting infectious diseases. We are a biotechnology company developing monoclonal antibodies to revolutionize the treatment of infectious diseases. We target diseases that impact people all around the world and cause hundreds of billions in economic burden annually. CONTACT US OUR MISSION IS TO AMELIORATE SUFFERING FROM INFECTIOUS DISEASES Monoclonal antibodies (mAbs) developed in our laboratory can be used for the treatment and prevention of infectious diseases and represent a powerful strategy for combating global and local epidemics. MABLOC has developed several mAbs (with its partners) that can be used for the treatment and prevention of infectious diseases ...

Text analysis

redirect type

0 (-)

block type

0 (no issues)

detected language

1 (English)

category id

Koronawirus (17)

index version

2025110801

spam phrases

0

Text statistics

text nonlatin

0

text cyrillic

0

text characters

3715

text words

669

text unique words

259

text lines

95

text sentences

36

text paragraphs

15

text words per sentence

18

text matched phrases

1

text matched dictionaries

3

RSS

rss status

32 (unknown)

rss found date

2024-04-19 22:22:51

rss size orig

16789

rss items

10

rss spam phrases

0

rss detected language

1 (English)

inbefore feed id

-

inbefore status

0 (new)

Sitemap

sitemap status

30 (processing completed, results pushed to table crawler_sitemaps.ext_domain_sitemap_lists)

sitemap review version

1

sitemap urls count

30

sitemap urls adult

0

sitemap filtered products

0

sitemap filtered videos

0

sitemap found date

2024-04-11 02:10:30

sitemap process date

2024-10-17 06:08:57

sitemap first import date

-

sitemap last import date

-